Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06378463
Other study ID # PSY-2324-S-0362
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date April 2027

Study information

Verified date April 2024
Source University of Groningen
Contact Lisette van der Meer, PhD
Phone +31628259303
Email l.van.der.meer@rug.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Seven per cent of patients suffering from severe mental illness (SMI) need long-term intensive treatment and support in a clinical setting or sheltered living. These service users often experience problems on multiple domains, such as persistent complaints as a result of medication resistance, physical health problems and self-care, psychosocial and cognitive dysfunctioning. Cognitive remediation (CR) training is a type of training aimed at improving thinking abilities (cognitive functioning) and daily functioning. However, we don't yet know if CR training can also help people with SMI who need supported housing due to their severe cognitive and daily living problems. In this project, we are investigating whether we can improve daily functioning in this group by using a form of CR training that focuses on learning new cognitive skills and how to use these new skills in everyday life. Additionally, we are exploring whether combining CR training with mild brain stimulation (transcranial Direct Current Stimulation) can enhance the effects of CR training.


Description:

A fundamental challenge for many people with severe mental illness (SMI) is dealing with the impact of cognitive impairments in daily life functioning. A possible treatment approach is cognitive remediation training (CR), a training developed to target cognitive deficits with the ultimate aim to improve daily functioning. Participants engage in cognitive exercises, learn more about their own cognition and the use of (cognitive) strategies to compensate for deficits. However, in people with SMI, abnormal synaptic plasticity is observed. This might hinder newly learned cognitive skills to sustain and limit the benefits from CR. For this reason, people with SMI may benefit from the combination of CR with a method that may promote neural plasticity: transcranial direct current stimulation (tDCS). In a pragmatic, triple-blinded, randomized, sham-controlled, multi-center trial with a multiple baseline design, we will investigate the effectiveness of combining CR and tDCS in helping participants reach personal goals, minimizing problems in daily functioning and improving cognitive functioning. 126 service users with SMI will receive 16-20 weeks of twice-weekly CR combined with active (N=63) or sham tDCS (N=63). We will perform functional, cognitive, and clinical outcome assessments at baseline, after a 16-week waiting period, post-treatment and 6-months post-treatment and compare the effects within-participants (waiting period vs. treatment period) and between-participants (CR+active tDCS vs. CR+sham tDCS). This multi-center trial will evaluate whether CR on its own and whether CR in combination with tDCS can be a clinically relevant addition to further enhance recovery through enhancing service users' goal attainment, daily functioning and cognitive performance. In case results of this trial confirm our hypotheses, it may be recommended to include the combined information in the guidelines for SMI care and to implement the method in standardized care.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 126
Est. completion date April 2027
Est. primary completion date April 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - A psychiatric disorder that requires care/treatment (no remission of positive, negative and cognitive symptoms); - Severe disabilities in social and/or societal functioning (no functional remission); - Disabilities are the result of a psychiatric disorder - Disabilities are structural (at least several years); - Coordinated professional care is necessary to realize a treatment plan. - Adults between the age of 18 and 65 Exclusion Criteria: - Metal implants inside the skull or eye; - Severe scalp skin lesions; - A history of previous seizures. - Alcohol or drug abuse;

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive remediation + active tDCS
The cognitive remediation program "Computerised Interactive Remediation of Cognition - a Training for Schizophrenia" (CIRCuiTS) improves cognitive and metacognitive skills and strategies and is specifically aimed at the generalization of newly learnt skills to daily life. This method also offers the possibility to personalize the training program based on individual goals and cognitive functioning of the service user. Transcranial Direct Current Stimulation is used to promote neural plasticity, which applies a small electrical current over the cortex. This can alter the excitability of neurons, such that it increases or decreases spontaneous network activity. When applied to fronto-parietal neural networks simultaneously with their engagement in cognitive tasks of CIRCuiTS, it is expected that plasticity of these networks will be modulated, resulting in improvements in cognitive functioning. In this condition, participants will receive active brain stimulation.
Cognitive remediation + sham tDCS
The cognitive remediation program "Computerised Interactive Remediation of Cognition - a Training for Schizophrenia" (CIRCuiTS) improves cognitive and metacognitive skills and strategies and is specifically aimed at the generalization of newly learnt skills to daily life. This method also offers the possibility to personalize the training program based on individual goals and cognitive functioning of the service user. Transcranial Direct Current Stimulation is used to promote neural plasticity, which applies a small electrical current over the cortex. This can alter the excitability of neurons, such that it increases or decreases spontaneous network activity. When applied to fronto-parietal neural networks simultaneously with their engagement in cognitive tasks of CIRCuiTS, it is expected that plasticity of these networks will be modulated, resulting in improvements in cognitive functioning. In this condition, participants will receive sham brain stimulation.

Locations

Country Name City State
Netherlands Cosis Assen Drenthe
Netherlands GGZ Friesland Leeuwarden Friesland
Netherlands Lentis Zuidlaren Drenthe

Sponsors (4)

Lead Sponsor Collaborator
University of Groningen GGZ Friesland, Lentis Psychiatric Institute, Stichting Cosis

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Independent Living Skills Survey self- and observer-rated questionnaire (ILSS) The Independent Living Skills Survey (ILSS) is a questionnaire that measures the basic functional living skills of individuals with SMI. The ILSS will be completed by the participant and by the participant's case manager. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Primary Goal Attainment Scale (GAS) This questionnaire is a measure to capture self-reported recovery goals in a structured way, which has also been used in rehabilitation practice. Based upon an interview, the participant defines up to three personal recovery goals that can be scored and weighted on importance and difficulty for which a scoring manual is available. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Controlled Oral World Association Task (COWAT) The COWAT is a test for verbal fluency and speed of processing. Participants have to name as many words as possible within a time span of 60 seconds, beginning with a given letter. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Trail Making Test (TMT) The Trail Making Test assesses visual search abilities, processing speed, and mental flexibility. Participants are provided with a sheet of paper, containing only digits or digits and letters, and are instructed to connect them in increasing order. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Digit span (forward & backward) The Digit Span forward is a test for immediate auditory attention. The Digit Span backward is a test for working memory. The test leader reads sequences of digits out loud, gradually increasing the digit span. The participant is asked to repeat the digits in the same order (forward) or reverse order (backward). Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Wechsler Memory Scale - Visual Reproduction I and II The Visual Reproduction subtest of the Wechsler Memory Scale (WMS) assesses visual memory for abstract designs. During this task, participants are presented with a series of designs. Each design is displayed for 10 seconds, after which the participant is asked to reproduce it from memory. After 30 minutes, a recognition task of the same designs is administered. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Stroop Color and Word Task (SCWT) The SCWT is used to test speed of processing, cognitive flexibility, and cognitive control. The participants first perform a basic task, which is reading names of colors. The performance on this task is compared with the performance on a task in which the ink color of incongruent color words has to be named. Hence, a habitual response needs to be suppressed in support of an unusual one. The increase in time taken to perform the latter task compared with the basic task is referred to as "the Stroop interference effect" and provides a general measure of executive functioning. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary 15 Word Test (15-WT) The 15-WT learning task is a test for verbal memory. The test leader reads 15 words out loud and participants are asked to recall as many words as possible. This procedure is repeated for four times. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Behavioral Assessment of the Dysexecutive System (BADS) - Key Search task The Key search task is a subtest of the BADS, a test battery used to evaluate executive functions. In this task, participants are asked to plan a search route for an imaginary lost key within a field. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Cognitive Failure Questionnaire (CFQ) The CFQ is a questionnaire to measure subjective cognitive functioning. The scale includes 25 questions that represent the cognitive subdomains attention and memory. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Self-Evaluation of Negative Symptoms (SNS) The SNS questionnaire assesses negative symptoms from the perspective of the service user. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary DEX self/informant The DEX questionnaire is a 20-item measure used to evaluate subjective cognitive performance, focusing on problems related to planning and organization. There are two versions of the questionnaire: one to be completed by the participant and the other by their case manager. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary General Self-Efficacy Scale (GSES) The GSES is a measure used to assess self-efficacy, the degree to which the respondent perceives himself or herself as capable of attaining goals, overcoming challenges, and performing well on tasks. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
Secondary Nurses' Observation Scale of Cognitive Abilities (NOSCA) The NOSCA is a behavioral rating scale to examine cognitive abilities in service users. The scale comprises eight subscales, representing subdomains of cognition. The answers are based on observations of a participants' case manager. Baseline (16 weeks before start of treatment), pre-treatment, post-treatment (after 16-20 weeks of treatment) and 6-months post-treatment
See also
  Status Clinical Trial Phase
Completed NCT02431299 - Illness Management and Recovery Treatment Integrity Scale Validation and Leadership Intervention Development N/A
Completed NCT05686304 - Effectiveness of Internet-based Self-help Money Management Program Among Adult With Severe Mental Illness N/A
Completed NCT02299492 - Person-Centered Care Planning and Service Engagement N/A
Not yet recruiting NCT05600205 - Evaluation of Combined Support for the Ambulatory Lifestyle Intervention N/A
Completed NCT01412866 - Electronic Decision Support Systems for Smokers With Severe Mental Illness N/A
Recruiting NCT05784818 - Up To Me: Erasing the Stigma of Mental Illness on College Campuses N/A
Completed NCT02453217 - The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial N/A
Recruiting NCT05432089 - The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization Phase 2
Active, not recruiting NCT05620212 - Investigating the Meaning and (Cost-)Effectiveness of Dutch Recovery Colleges
Completed NCT03075800 - Integration of Illness Management and Recovery Within ACT N/A
Recruiting NCT03566069 - Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness Phase 2
Completed NCT05041634 - Physical Activity for People With Behavioral Diagnoses N/A
Recruiting NCT01182012 - Reduction of Cardiovascular Risk in Severe Mental Illness Phase 4
Completed NCT05491174 - Mental Health Intervention for Transdiagnostic Groups in the Community N/A
Recruiting NCT04337398 - Exercise in Severe Mental Illness. The PsychiActive Project 2.0 N/A
Not yet recruiting NCT04314154 - Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric Patients